|
ESF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.499420E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.918400E-01 |
| Normal-vs-Stage2 |
6.552200E-01 |
| Normal-vs-Stage3 |
1.495150E-01 |
| Normal-vs-Stage4 |
3.868000E-01 |
| Stage1-vs-Stage2 |
8.258400E-01 |
| Stage1-vs-Stage3 |
1.523960E-01 |
| Stage1-vs-Stage4 |
7.879800E-01 |
| Stage2-vs-Stage3 |
4.615800E-01 |
| Stage2-vs-Stage4 |
9.323000E-01 |
| Stage3-vs-Stage4 |
4.567000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.480840E-01 |
| Normal-vs-AfricanAmerican |
7.722600E-01 |
| Normal-vs-Asian |
4.728400E-01 |
| Caucasian-vs-AfricanAmerican |
4.739000E-01 |
| Caucasian-vs-Asian |
7.233000E-01 |
| AfricanAmerican-vs-Asian |
5.123200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.898800E-01 |
| Normal-vs-Female |
5.263700E-03 |
| Male-vs-Female |
7.015900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.618600E-01 |
| Normal-vs-Extreme_Weight |
2.982000E-01 |
| Normal-vs-Obese |
1.917010E-01 |
| Normal-vs-Extreme_Obese |
5.710200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.940000E-01 |
| Normal_Weight-vs-Obese |
5.576000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.652800E-01 |
| Extreme_Weight-vs-Obese |
4.991600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.975000E-01 |
| Obese-vs-Extreme_Obese |
7.494600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.074300E-02 |
| Normal-vs-Age(41-60Yrs) |
4.734200E-02 |
| Normal-vs-Age(61-80Yrs) |
9.488400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.529700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.349820E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.357700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.738300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.943800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.136400E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.462000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.003000E-01 |
| Normal-VS-Type2 PRCC |
7.894000E-01 |
| Normal-VS-KIRP CIMP |
2.050400E-01 |
| Normal-VS-Unclassified PRCC |
2.478000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.968600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.264200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.626100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.342200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.119900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.206800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.828400E-01 |
| Normal-vs-N1 |
1.778200E-02 |
| Normal-vs-N2 |
5.109000E-01 |
| N0-vs-N1 |
9.303200E-03 |
| N0-vs-N2 |
8.495200E-01 |
| N1-vs-N2 |
2.235800E-01 |
|
|
